356 related articles for article (PubMed ID: 27906525)
1. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.
Eskreis-Winkler S; Zhang Y; Zhang J; Liu Z; Dimov A; Gupta A; Wang Y
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27906525
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility-weighted imaging: current status and future directions.
Liu S; Buch S; Chen Y; Choi HS; Dai Y; Habib C; Hu J; Jung JY; Luo Y; Utriainen D; Wang M; Wu D; Xia S; Haacke EM
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192086
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of R
Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
[TBL] [Abstract][Full Text] [Related]
4. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional quantitative susceptibility mapping from standard fMRI studies.
Sun H; Seres P; Wilman AH
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27687150
[TBL] [Abstract][Full Text] [Related]
6. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases.
Ravanfar P; Loi SM; Syeda WT; Van Rheenen TE; Bush AI; Desmond P; Cropley VL; Lane DJR; Opazo CM; Moffat BA; Velakoulis D; Pantelis C
Front Neurosci; 2021; 15():618435. PubMed ID: 33679303
[TBL] [Abstract][Full Text] [Related]
8. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice.
Bandt SK; de Rochefort L; Chen W; Dimov AV; Spincemaille P; Kopell BH; Gupta A; Wang Y
World Neurosurg; 2019 Feb; 122():e10-e19. PubMed ID: 30201583
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
[TBL] [Abstract][Full Text] [Related]
10. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
[TBL] [Abstract][Full Text] [Related]
11. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
[TBL] [Abstract][Full Text] [Related]
12. Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
Liu T; Eskreis-Winkler S; Schweitzer AD; Chen W; Kaplitt MG; Tsiouris AJ; Wang Y
Radiology; 2013 Oct; 269(1):216-23. PubMed ID: 23674786
[TBL] [Abstract][Full Text] [Related]
13. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
14. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
16. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
[TBL] [Abstract][Full Text] [Related]
17. Deep grey matter iron accumulation in alcohol use disorder.
Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
[TBL] [Abstract][Full Text] [Related]
18. Importance of extended spatial coverage for quantitative susceptibility mapping of iron-rich deep gray matter.
Elkady AM; Sun H; Wilman AH
Magn Reson Imaging; 2016 May; 34(4):574-8. PubMed ID: 26721523
[TBL] [Abstract][Full Text] [Related]
19. Overview of quantitative susceptibility mapping.
Deistung A; Schweser F; Reichenbach JR
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27434134
[TBL] [Abstract][Full Text] [Related]
20. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
